Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?
about
Remodeling Components of the Tumor Microenvironment to Enhance Cancer TherapyPractical management of bevacizumab-related toxicities in glioblastomaToward a science of tumor forecasting for clinical oncology.Bevacizumab in recurrent glioblastoma: five informative patient scenarios.Bevacizumab in recurrent glioblastoma: open issues.
P2860
Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Can bevacizumab prolong surviv ...... ugh multiple lines of therapy?
@en
Can bevacizumab prolong surviv ...... ugh multiple lines of therapy?
@nl
type
label
Can bevacizumab prolong surviv ...... ugh multiple lines of therapy?
@en
Can bevacizumab prolong surviv ...... ugh multiple lines of therapy?
@nl
prefLabel
Can bevacizumab prolong surviv ...... ugh multiple lines of therapy?
@en
Can bevacizumab prolong surviv ...... ugh multiple lines of therapy?
@nl
P2093
P2860
P356
P1433
P1476
Can bevacizumab prolong surviv ...... ugh multiple lines of therapy?
@en
P2093
Alba A Brandes
Antoine F Carpentier
Beatrix Lutiger
Cedric Revil
Frank Saran
Josef Pichler
Miguel Gil
Warren Mason
P2860
P304
P356
10.2217/FON.14.75
P407
P577
2014-05-01T00:00:00Z